All relevant data are within the paper.

Introduction {#sec005}
============

The yield of essential oils is one of the fundamental factors affecting the quality of herb teas or dietary supplements containing such raw materials. Many essential oils have medicinal properties which make them useful in the treatment of various diseases and pathological conditions \[[@pone.0130714.ref001]\]. The oils are characterized by a broad spectrum of activity, i.e. antibacterial, anti-fungal, anti-parasitic, anti-inflammatory, diuretic, cholagogic, apoflegmatic, irritating, lowering the activity of the central nervous system, soporific, sedative or stimulating, anti-depressive, anticonvulsive, and also as an antioxidant (scavengers of free peroxide radicals), immuno-stimulating and anti-carcinogenic \[[@pone.0130714.ref002], [@pone.0130714.ref003]\].

In view of the above, the objective of the undertaken study was to estimate potential availability of essential oil in some brands of herbal products. A comparison was performed on the basis of the yield of essential oil in the unprocessed raw materials, such as the leaf of peppermint, leaf of lemon balm and inflorescence of chamomile in relation to the herbal tea bags used for brewing and in dietary supplements whose composition included those herbal raw materials.

Materials and Methods {#sec006}
=====================

Ethics Statement {#sec007}
----------------

The study was carried out on private land. The owner of the land gave permission to conduct the study on this site: no specific permissions were required for these locations/activities,the field studies did not involve endangered or protected species.

Plant Materials and Products {#sec008}
----------------------------

The experimental material consisted of the following raw materials and products: Leaves of peppermint (*Mentha piperita* L.), leaves of lemon balm (*Melissa officinalis* L.) and inflorescence of chamomile (*Matricaria chamomilla* L.), acquired from retail shops in the Lublin Region (eastern Poland) and from cultivation in an allotment garden (Lubartów, N 51°27\' 41.0394\", E 22°37\' 5.8152\", located in the eastern part of the Lubartów Upland which forms a part of the much larger South Podlasie Lowland). Leaves and inflorescences were harvested at maturity pooled (June 2013). Lemon balm and mint acquired in the second year of cultivation, while chamomile are obtained from annual plants. The plant material is dried in a room free from air circulation in low temperature.Herbal tea bags: peppermint, lemon balm, and chamomile, purchased in Lublin markets.Dietary supplements (in the form of capsules, liquids and powders), containing peppermint, lemon balm and chamomile in their composition, purchased in Lublin pharmacies.

A listing of the raw materials and products is given in [Table 1](#pone.0130714.t001){ref-type="table"}.

10.1371/journal.pone.0130714.t001

###### Unprocessed materials and products used in the study.

![](pone.0130714.t001){#pone.0130714.t001g}

  Component                     Group                  Form processing raw material/product   The content of the ingredient in the minimum dose (serving)   Code
  ----------------------------- ---------------------- -------------------------------------- ------------------------------------------------------------- ------
  ***Mentha piperita***         unprocessed material   dry material                           not applicable                                                cMT1
  not applicable                cMT2                                                                                                                        
  not applicable                cMT3                                                                                                                        
  not applicable                cMT4                                                                                                                        
  herbal tea                    tea bags to brew       2000 mg                                tMT1                                                          
  2000 mg                       tMT2                                                                                                                        
  2000 mg                       tMT3                                                                                                                        
  2000 mg                       tMT4                                                                                                                        
  2250 mg                       tMT5                                                                                                                        
  2000 mg                       tMT6                                                                                                                        
  2000 mg                       tMT7                                                                                                                        
  2000 mg                       tMT8                                                                                                                        
  dietary supplement            tablets                1000 mg                                sMT1                                                          
  capsules                      820 mg                 sMT2                                                                                                 
  capsules                      28,3 mg                sMT3                                                                                                 
  tablets                       1000 mg                sMT4                                                                                                 
  liquid                        130 mg                 sMT5                                                                                                 
  tablets                       9 mg                   sMT6                                                                                                 
  tablets                       60 mg                  sMT7                                                                                                 
  tablets                       150 mg                 sMT8                                                                                                 
  tablets                       1000 mg                sMT9                                                                                                 
  tablets                       350 mg                 sMT10                                                                                                
  ***Melissa officinalis***     unprocessed material   dry material                           not applicable                                                cML1
  not applicable                cML2                                                                                                                        
  not applicable                cML3                                                                                                                        
  not applicable                cML4                                                                                                                        
  herbal tea                    tea bags to brew       1500 mg                                tML1                                                          
  2000 mg                       tML2                                                                                                                        
  2000 mg                       tML3                                                                                                                        
  2000 mg                       tML4                                                                                                                        
  1700 mg                       tML5                                                                                                                        
  2000 mg                       tML6                                                                                                                        
  2000 mg                       tML7                                                                                                                        
  2000 mg                       tML8                                                                                                                        
  dietary supplement            tablets                50 mg                                  sML1                                                          
  capsules                      600 mg                 sML2                                                                                                 
  liquid                        150 mg                 sML3                                                                                                 
  liquid                        750 mg                 sML4                                                                                                 
  powder                        1380 mg                sML5                                                                                                 
  tablets                       1050 mg                sML6                                                                                                 
  tablets                       50 mg                  sML7                                                                                                 
  capsules                      30 mg                  sML8                                                                                                 
  powder                        1250 mg                sML9                                                                                                 
  capsules                      3000 mg                sML10                                                                                                
  ***Matricaria chamomilla***   unprocessed material   dry material                           not applicable                                                cMC1
  not applicable                cMC2                                                                                                                        
  not applicable                cMC3                                                                                                                        
  not applicable                cMC4                                                                                                                        
  herbal tea                    tea bags to brew       1500 mg                                tMC1                                                          
  1500 mg                       tMC2                                                                                                                        
  1500 mg                       tMC3                                                                                                                        
  1500 mg                       tMC4                                                                                                                        
  2000 mg                       tMC5                                                                                                                        
  1750 mg                       tMC6                                                                                                                        
  1500 mg                       tMC7                                                                                                                        
  1750 mg                       tMC8                                                                                                                        
  dietary supplement            liquid                 200 mg                                 sMC1                                                          
  capsules                      147 mg                 sMC2                                                                                                 
  capsules                      140 mg                 sMC3                                                                                                 
  liquid                        375 mg                 sMC4                                                                                                 
  capsules                      200 mg                 sMC5                                                                                                 
  tablets                       150 mg                 sMC6                                                                                                 
  capsules                      675 mg                 sMC7                                                                                                 
  liquid                        1000 mg                sMC8                                                                                                 
  powder                        1500 mg                sMC9                                                                                                 
  capsules                      1300 mg                sMC10                                                                                                

Qualitative and Quantitative Analysis of Essential Oil {#sec009}
------------------------------------------------------

### Assay of essential oil yield {#sec010}

The yield of essential oil in the raw materials and in the herbal teas was analysed with the method of distillation. With the food-product character of herbal teas and oral application of dietary supplements it can be assumed that the essential oil contained in them is absorbed by the human organism and constitutes a quantitatively potentially available level of biologically active substances that may exhibit activity within the broad spectrum of their properties. The potential availability of essential oil after consuming such teas and dietary supplements was determined with the method of calculation on the basis of the minimum and maximum dose (portion) recommended by the producers, with the assumption that the yield of essential oil in the herbal component corresponds to the average yield of that component in the respective herbal tea.

The distillation of peppermint and chamomile essential oils (raw materials and herbal teas) was conducted in a Clevenger-type apparatus, according to the Polish Pharmacopoeia VIII \[[@pone.0130714.ref004]\]. The time of the distillation was deemed appropriate for the procedure contained in the detailed monograph and amounted to 3 hours for peppermint and 2 hours for chamomile.

For lemon balm (raw materials and herbal teas), due to the lack of a detailed monograph in PP VIII \[[@pone.0130714.ref004]\], we referred to the monograph in PP VI \[[@pone.0130714.ref005]\], where the distillation time is 3 hours. The method of the direct distillation was applied for lemon balm, and the indirect method (with xylene) was used for chamomile and peppermint. For this purpose, 20.0 g of inflorescences or leaves, 400 ml water and 0.30 ml of xylene was used. A flask of 1000 cm^3^ was used. Water was poured onto the weighed material in the flask and then the xylene was added to the flask. After being brought to the boil and the first drop being distilled the flask continued to be heated for 3 h. 30 min after finishing distillation the result was read and xylene correction (0.26 ml) was subtracted from the reading. The measured essential oil volume was counted for 100 g of material.

The distillation was carried out in triplicate. The oil was recovered directly and was stored with anhydrous sodium sulfate in dark vials at 4°C.

### GC analysis {#sec011}

Essential oil (10 μl) was diluted 1:100 using *n*-hexane to achieve 1 ml volume, then 100 μl of C12, and C19 as internal standards mixture solution (1 mg/ml in toluene) was added to the diluted oil. Such prepared samples were subjected to GC-MS and GC-FID evaluations. Chromatographic separations were performed in triplicate.

Reproducibility has been evaluated for the chromatographic analysis of volatile compounds standards in order to verify the accuracy of the chromatographic separation. Carried out after 10 measurements. Then, in order to detect and eliminate questionable results, the data obtained was verified using the Grubbs test. The values of the coefficients of variation for the reproducibility of the method ranged from 0.00% to 9.10%, so they were less than 10%, which demonstrates the reproducibility of the method and its usefulness in the experiment carried out \[[@pone.0130714.ref006]\].

### GC/MS {#sec012}

GC-MS: ITMS Varian 4000 GC-MS/MS (Varian, USA) equipped with a CP-8410 auto-injector and a 30 m x 0.25 mm VF-5ms column (Varian, USA), film thickness 0.25 μm, carrier gas He 0.5 ml/min, injector and detector temperature were, respectively, at 250 and 200°C; split ratio 1:50; inject volume 5 μl. A temperature gradient was applied (50°C for 1 minute, then increased by 4°C/min to 250°C, 250°C for 10 minutes); ionization energy 70 eV; mass range: 40--870 Da; scan time 0.80 s. Data acquisition and processing, and instrumental control were performed by the Varian MS Workstation Version 6.42.

### GC/FID {#sec013}

GC Varian 3800 (Varian, USA) equipped with a CP-8410 auto-injector and a 30 m x 0.25 mm DB-5 column (J&W Scientific, USA), film thickness 0.25 μm, carrier gas He 0.5 ml/min, injector and detector FID temperatures were, 260°C; split ratio 1:100; inject volume 5 μl. A temperature gradient was applied (50°C for 1 minute, then increased by 4°C/min to 250°C, 250°C for 10 minutes).

### Qualitative analysis {#sec014}

The qualitative analysis was carried out on the basis of MS spectra which were compared with the spectra library by means of the NIST MS Search Program (NIST 08, Software Version 2.0f) \[[@pone.0130714.ref007]\], and with the data available in literature \[[@pone.0130714.ref008], [@pone.0130714.ref009]\]. Identity of the compounds was confirmed by their retention indices \[[@pone.0130714.ref010]\], taken from literature \[[@pone.0130714.ref008], [@pone.0130714.ref009]\], and our own data for standards (1,8-cineole, chamazulene, eugenol, limonene, menthone, thymol, carvone, carvacrol, menthol, caryophyllene oxide, E-caryophyllene from Fluka, Sigma-Aldrich Chemie GmbH, Germany).

### Quantitative analysis {#sec015}

The percentage of main components of the essential oil was presented assuming that the sum of peak areas for all identified constituents is 100%.

Only main components of essential oil were selected on a base of the concentration criterion--\>1.0%, although in the one essential oil.

### Statistical Methods {#sec016}

All variables showed normal distribution, when analyzed using the Shapiro-Wilk normality test, and therefore, the parametric statistical analysis was used. Data were expressed as mean ± standard error of mean. The variables were compared among groups by one-way analysis of variance (ANOVA). For cases in which some significance was shown, post hoc Duncan's test was used. For all analyses, we adopted the significance level of *P* \< 0.05. The software used for statistical analysis was SAS statistical system (SAS Version 9.1, SAS Inst., Cary, N.C., U.S.A.).

Results and Discussion {#sec017}
======================

[Table 2](#pone.0130714.t002){ref-type="table"} presents the yield of essential oil in non-fragmented unprocessed raw materials such as the leaves of peppermint, leaves of lemon balm, and inflorescence of chamomile, and in herbal teas from those herb species. [Table 3](#pone.0130714.t003){ref-type="table"} presents data concerning the potential availability of essential oil after the consumption of the herbal teas and dietary supplements.

10.1371/journal.pone.0130714.t002

###### The yield of essential oils in the analyzed unprocessed materials and tea bags.

![](pone.0130714.t002){#pone.0130714.t002g}

  Yield of essential oil \[% v/w±SD\]                                                                      
  --------------------------------------------- -------------- ------------- --------------- ------------- ---------------
  cMT1[^\#^](#t002fn002){ref-type="table-fn"}   1.32 ± 0.04e   cML1          0.18 ± 0.01ab   cMC1          0.43 ± 0.00f
  cMT2                                          1.84 ± 0.04c   cML2          0.17 ± 0.01bc   cMC2          0.41 ± 0.04f
  cMT3                                          2.19 ± 0.05b   cML3          0.19 ± 0.01a    cMC3          0.74 ± 0.04a
  cMT4                                          2.48 ± 0.05a   cML4          0.18 ± 0.01ab   cMC4          0.45 ± 0.04ef
  average cMT                                   1.96           average cML   0.18            average cMC   0.51
  PPVIII norm                                   \>1.20         PPVI norm     \>0.05          PPVIII norm   \>0.40
  tMT1                                          1.61 ± 0.03d   tML1          0.12 ± 0.02e    tMC1          0.56 ± 0.03cb
  tMT2                                          1.31 ± 0.04e   tML2          0.08 ± 0.01f    tMC2          0.48 ± 0.03de
  tMT3                                          0.87 ± 0.03g   tML3          0.16 ± 0.02cd   tMC3          0.49 ± 0.01de
  tMT4                                          1.28 ± 0.03e   tML4          0.09 ± 0.01f    tMC4          0.50 ± 0.01ef
  tMT5                                          0.25 ± 0.00j   tML5          0.09 ± 0.01f    tMC5          0.35 ± 0.00g
  tMT6                                          1.11 ± 0.03f   tML6          0.14 ± 0.01d    tMC6          0.33 ± 0.03g
  tMT7                                          0.58 ± 0.03h   tML7          0.07 ± 0.01f    tMC7          0.54 ± 0.00c
  tMT8                                          0.52 ± 0.03i   tML8          0.17 ± 0.01ab   tMC8          0.59 ± 0.01b
  average tMT                                   0.94           average tML   0.12            average tMC   0.48
  cMT/tMT                                       2.09           cML/tML       1.50            cMC/tMC       1.06
  PPVIII norm                                   \>0.90         PPVI norm     \>0.05          PPVII norm    \>0.40

The *F* values (one way ANOVA) are shown in the table. The levels of significance are indicated by an asterisk (\*\*0.001 \<*P*≤0,01; \*\*\**P* ≤0,001).

^\#^Designation according to [Table 1](#pone.0130714.t001){ref-type="table"}.

a, b, c ...---values designated with the same letters (a, b, c, d) within columns do not significantly differ at 5% error (Duncan's test).

10.1371/journal.pone.0130714.t003

###### The potential availability of essential oil for consumption of herbal teas and dietary supplements.

![](pone.0130714.t003){#pone.0130714.t003g}

  The potential availability of essential oil \[mg\]                                                                                
  ---------------------------------------------------- -------- -------- ------------- --------- ----------- ------------- -------- ---------
  tMT1[^\#^](#t003fn004){ref-type="table-fn"}          32.20a   96.60a   tML1          1.80d     5.40c       tMC1          8.40b    25.20b
  tMT2                                                 26.20b   78.60b   tML2          1.60def   4.80cd      tMC2          7.20cd   21.60cd
  tMT3                                                 17.40d   52.20d   tML3          3.20b     9.60a       tMC3          7.35cd   22.05cd
  tMT4                                                 25.60b   76.80b   tML4          1.80d     5.40c       tMC4          7.50c    22.50c
  tMT5                                                 5.62i    16.88h   tML5          1.53def   4.59cde     tMC5          7.00d    21.00d
  tMT6                                                 22.20c   66.60c   tML6          2.80c     8.40b       tMC6          5.78f    17.32e
  tMT7                                                 11.60e   34.80e   tML7          1.40ef    4.20def     tMC7          8.10b    24.30b
  tMT8                                                 10.40f   31.20f   tML8          3.40ab    10.20a      tMC8          10.32a   30.98a
  average tMT                                          18.90    56.7     average tML   2.19      6.57        average tMC   7.71     23.12
  sMT1                                                 9.40g    18.80h   sML1          0.06h     0.22i       sMC1          0.96j    2.88i
  sMT2                                                 7.71h    23.12g   sML2          0.72g     0.72i       sMC2          0.71j    2.11ij
  sMT3                                                 0.27m    1.60k    sML3          0.18h     0.36i       sMC3          0.67j    6.05g
  sMT4                                                 9.40g    18.80h   sML4          0.90g     0.27g       sMC4          1.80i    5.40gh
  sMT5                                                 1.22kl   2.44k    sML5          1.66de    1.66h       sMC5          0.96j    0.96k
  sMT6                                                 0.08m    1.03k    sML6          1.26f     3.78f       sMC6          0.72j    1.44jk
  sMT7                                                 0.56lm   5.08j    sML7          0.06h     0.36i       sMC7          3.24h    12.96f
  sMT8                                                 1.41k    2.82k    sML8          0.04h     0.04i       sMC8          4.80g    4.80h
  sMT9                                                 9.40g    18.80h   sML9          1.50def   4.50cdef    sMC9          7.20cd   21.60cd
  sMT10                                                3.29j    9.87i    sML10         3.60a     3.60~~f~~   sMC10         6.24e    12.48f
  average sMT                                          4.27     10.24    average sML   1.00      1789        average sMC   2.73     7.07
  tMT/sMT                                              4.42     5.54     tML/sML       2.19      3.67        tMC/sMC       2.82     3.27

The *F* values (one way ANOVA) are shown in the table. The levels of significance are indicated by an asterisk

\*\*0.001 \<*P*≤0,01;

\*\*\**P* ≤0,001.

^\#^Designation according to [Table 1](#pone.0130714.t001){ref-type="table"}.

a, b, c ...---values designated with the same letters (a, b, c, d) within columns do not significantly differ at 5% error (Duncan's test).

Peppermint {#sec018}
----------

The yield of essential oil in the unprocessed raw material---leaf of peppermint, varied from 1.32% to 2.48% (mean of 1.96%). Leaves of peppermint can contain from 0.5 to 5.0% of oil \[[@pone.0130714.ref011]\]. The pharmacopeial raw material of peppermint *Mentha piperita* L. consists of whole or shredded dried leaves which should contain no less than 1.2% of the essential oil for non-fragmented plant material and a lot less than 0.9% in the case of shredded plant material \[[@pone.0130714.ref004]\]. The criterion of Polish Pharmacopoeia VIII \[[@pone.0130714.ref004]\] concerning the yield of volatile substances was met by five herbal teas. The concentration of essential oil in the herbal teas analysed varied from 0.25 to 1.61% (mean of 0.94%) and on average it was circa twice lower than in the unprocessed material ([Table 2](#pone.0130714.t002){ref-type="table"}). The difference between the extreme concentrations was 2.23%, which may largely be an effect of raw material processing during production of the herbal teas, aside from its possibly quite varied initial quality.

The yield of volatile substances is affected by the degree of fragmentation of the raw material. The process of fragmentation results in the destruction of secretory structures and liberation of essential oil in the course of the technological process, and thus reduces the yield of essential oil in the final product. As Kowalski and Wawrzykowski report \[[@pone.0130714.ref012]\], the process of granulation, to which herbal materials can be subjected for the production of herbal teas for the purpose of homogenisation of a batch of raw material, may lead to a notable reduction of the yield of essential oil in relation to the initial raw material. For example, in the case of peppermint the concentration of essential oil in the granulate decreased by circa 71% in relation to the non-shredded material (1.08% and 0.31%, respectively).

In the case of analyses of dietary supplements containing peppermint leaf in their composition it was found that the average potential availability of essential oils supplied to the organism with products of the type of dietary supplements, for the recommended doses, was significantly lower than in the corresponding peppermint tea brews, as much as ca. 6-fold lower---the maximum value of potential availability of essential oil for peppermint tea is 96.60 mg (min. 5.62 mg), while the corresponding value for the dietary supplement is at the level of 23.12 mg (min. 0.08 mg).

Potential availability of essential oil for the analysed forms of dietary supplements was generally significantly different. Taking into account a minimum daily intake of essential oil, the highest availability of this substance can be noticed in tablets which contain peppermint leaves--9.40 mg (sMT1, sMT4, sMT9). However, this type of supplements contained the lowest amount of essential oil: 0.08 mg (sMT6). For the maximum daily intake, the highest potential availability of essential oil was present in the capsules--23.12 mg (sMT2) as well as the tablets and the liquid--18.80 mg (sMT1, sMT4, and sMT9).

Góra and Lis \[[@pone.0130714.ref013]\] report that approximately 150 components of peppermint essential oil have been identified to date, the main ones being menthol (20--80%) and menthone (15--45%).

The following components have been identified in the *M*. *piperita* essential oil: menthol (33--60%), menthone (15--32%), isomenthone (2--8%), 1,8-cineole (5--13%), menthyl acetate (2--11%), menthofuran (1--10%), limonene (1--7%), -myrcene (0.1--1.7%), -caryophyllene (2--4%), pulegone (0.5--1.6%) and carvone (1%) \[[@pone.0130714.ref014]\]. Taking into account the classification of those authors, the peppermint teas in the experiment belong to a chemotype rich in menthol, menthone and iso-menthone.

According to PP VIII \[[@pone.0130714.ref004]\], the levels of the main components of peppermint oil should fall within the following ranges: menthone 14--32%, iso-menthone 1.5--10%, menthyl acetate 2.8--10%, and menthol 30--55%.

The unprocessed raw material was characterised by the presence of the following main components isolated from the essential oil: menthol (23.4--29.5%), menthone (26.9--38.4%), menthyl acetate (7.8--15.8%) and iso-menthone (7.0--12.3%)--[Table 4](#pone.0130714.t004){ref-type="table"}. The peppermint oils analysed differed very slightly in their chemical composition. The dominant components in oils from the peppermint teas included menthol (23.6--40.8%), menthone (26.0--41.7%), menthyl acetate (5.3--7.9%), iso-menthone (3.9--7.2%) and neo-menthol (4.1--7.4%).

10.1371/journal.pone.0130714.t004

###### The main components of essential oils obtained from unprocessed materials and peppermint teas.

![](pone.0130714.t004){#pone.0130714.t004g}

                               cMT1[^\#^](#t004fn001){ref-type="table-fn"}   cMT2   cMT3   cMT4   tMT1   tMT2   tMT3   tMT4   tMT5   tMT6   tMT7   tMT8                                                                           
  --------------------- ------ --------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -----
  **1,8-cineole**       1037   2.6                                           0.1    4.5    0.0    2.5    0.2    3.2    0.1    2.6    0.1    2.1    0.1    1.7    0.0   2.4    0.1   1.4    0.0   1.6    0.0   2.0    0.0   1.8    0.0
  **menthone**          1168   26.9                                          0.2    33.8   0.9    38.4   0.1    37.9   0.3    26.0   0.6    33.1   0.3    39.2   0.6   41.7   0.4   33.4   0.3   38.2   0.5   32.9   0.2   28.9   0.3
  **iso-menthone**      1175   12.3                                          0.2    7.6    0.0    7.0    0.2    7.5    0.1    3.9    0.2    5.5    0.1    7.2    0.2   6.8    0.1   6.1    0.1   4.9    0.1   5.1    0.1   4.8    0.1
  **neo-menthol**       1179   2.9                                           0.1    2.4    0.1    2.4    0.1    2.7    0.1    4.1    0.2    5.9    0.2    7.4    0.2   7.2    0.1   6.5    0.1   5.3    0.1   5.5    0.1   5.2    0.1
  **menthol**           1193   29.5                                          0.3    28.0   0.5    26.9   0.2    23.4   0.2    39.4   0.5    36.2   0.1    25.8   0.4   23.6   0.5   33.1   0.1   32.1   0.2   37.1   0.6   40.8   0.5
  **pulegone**          1249   1.4                                           0.0    0.1    0.0    \-     \-     0.3    0.0    1.9    0.1    0.5    0.0    0.6    0.0   0.5    0.0   0.6    0.0   0.8    0.0   0.7    0.0   1.0    0.0
  **piperitone**        1266   1.3                                           0.0    1.2    0.0    tr.    \-     0.7    0.1    3.3    0.1    1.0    0.0    1.3    0.0   1.3    0.0   1.4    0.0   1.0    0.0   1.1    0.0   1.5    0.0
  **menthyl acetate**   1296   7.8                                           0.1    9.3    0.1    15.8   0.6    10.5   0.2    5.3    0.1    7.9    0.2    6.5    0.1   5.7    0.4   7.2    0.4   6.0    0.4   6.8    0.4   tr.    ---
  **germacrene D**      1489   1.4                                           0.1    2.0    0.1    1.5    0.0    3.7    0.1    1.9    0.0    1.7    0.0    2.5    0.1   2.7    0.1   2.5    0.1   2.6    0.4   1.5    0.0   1.1    0.0

^\#^Designation according to [Table 1](#pone.0130714.t001){ref-type="table"}.

IR- retention indices (from temperature-programming, using definition of Van den Dool and Kratz \[[@pone.0130714.ref010]\].

tr.---less than 0.1%.

In the oils isolated in the experiment the content of menthone was higher than the range indicated in the PP VIII \[[@pone.0130714.ref004]\] while the levels of iso-menthone and ethyl acetate were conforming to the PP VIII \[[@pone.0130714.ref004]\], and two oils were characterised by menthol levels below 30%.

Peppermint is used in EU countries both as food as a medicinal product. The use of the raw material in amounts commonly occurring in food products is safe. In the USA, peppermint has the status of GRAS (Generally Recognized as Safe, FDA). The material was commonly used as a food component in Poland before 1997. Extracts from leaves are used as medical potions for improving digestion, and with diastolic and cholagogic effects. Leaves of peppermint are a component of many herbal blends \[[@pone.0130714.ref015]\]. Peppermint is used for the production of peppermint oil whose main component is menthol \[[@pone.0130714.ref016]\]. A single medicinal dose is 3--6 g of raw material or 5--15 g of tincture \[[@pone.0130714.ref017]\], 1,5--3 g of raw material 3 times a day \[[@pone.0130714.ref016]\], 4--9 g of raw material daily (divided into portions) \[[@pone.0130714.ref018]\].

Lemon balm {#sec019}
----------

Essential oil yield in raw material---leaf of lemon balm varied from 0.17% to 0.19% (mean of 0.18%)--[Table 2](#pone.0130714.t002){ref-type="table"}, while the level on essential oil in lemon balm teas varied within the range of 0.07--0.17% (mean of 0.12%). The pharmacopeial raw materials are dried leaves of *Melissa officinalis* L. The standard acc. to PP VI \[[@pone.0130714.ref005]\] states that leaves of lemon balm should contain not less than 0.05% of oil, and thus all of the herbal teas under analysis complied with that requirement, which indicates good quality of the used raw material. The lemon balm teas were characterised by, on average, one a half lower yield of essential oil compared to the unprocessed raw material. The mean potential availability of essential oil in dietary supplements with lemon balm, for the recommended doses, was four times lower than in the teas---the maximum value of potential availability of essential oil for lemon balm tea is 10.20 mg (min. 1.40 mg), while the corresponding value for the dietary supplement is at the level of 4.50 mg (min 0.04 mg).

For the minimum recommended daily intake of supplements containing lemon balm the statistically highest potential availability of essential oil can be found in the capsules--3.60 mg (sML10), and in powders--1.66 mg and 1.50 mg (sML5, sML9). The potentially lowest available amount of essential oil for minimum daily intakes was found in the capsules--0.04 mg (sML8), and the tablets--0.06 mg (sML1 and sML7). For the maximum daily intake, the highest potential availability of essential oil can be observed in the powder--4.50 mg (sML9)--3.78 mg and 3.60 mg (sML6 and sML10).

Góra and Lis \[[@pone.0130714.ref013]\] report that the qualitative composition of lemon balm oil is subject to notable variation and large differences were observed in the levels of the main components, these findings are supported by this study. The authors cited state that the dominant components of lemon balm oil are citronellal (11.31%), neral (22.18%) and geranial (33.6%). In lemon balm oils obtained from leaves and green parts of plants grown in Poland the following main components were assayed: β-caryophyllene (5.88--31.73%), caryophyllene oxide (0.01--12.2%), geranial (6.27--32.92%), neral (4.59--17.37%) and citronellal (1.33--15.18%) \[[@pone.0130714.ref019]\]. In essential oils isolated from lemon balm grown in Greece 45 components were identified, the dominant ones being beta-pinene, sabinene, E-caryophyllene and caryophyllene oxide \[[@pone.0130714.ref020]\].

The unprocessed raw material was characterised by the presence of the following main components isolated from the essential oil: geranial (8.6--32.1%), neral (4.1--20.6%), caryophyllene oxide (20.2--36.0%), E-caryophyllene (1.7--9.1%), citronellal (5.2--18.3%)--[Table 5](#pone.0130714.t005){ref-type="table"}. In the analysed lemon balm teas 117 components of essential oil were identified. The qualitative composition of the lemon balm tea essential oils is quite similar, while quantitative variation was noted for the particular components. The dominant compounds in lemon balm oil from the teas are geranial (3.6--38.5%), neral (2.9--26.5%), menthyl acetate (1.0--37.4%), caryophyllene oxide (5.6--19.9%), E-caryophyllene (3.8--9.2%), citronellal (0.4--8.7%) ([Table 5](#pone.0130714.t005){ref-type="table"}).

10.1371/journal.pone.0130714.t005

###### The main components of essential oils obtained from unprocessed materials and lemon balm teas.

![](pone.0130714.t005){#pone.0130714.t005g}

                                                  cML1\*   cML2   cML3   cML4   tML1   tML2   tML3   tML4   tML5   tML6   tML7   tML8                                                                           
  ---------------------------------------- ------ -------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -----
  **limonene**                             1033   \-              0.1    0.0    \-     \-     \-     \-     1.4    0.0    1.0    0.1    0.4    0.0   1.8    0.2   0.8    0.1   4.4    0.2   1.0    0.1   1.9    0.1
  **citronellal**                          1158   \-              8.5    0.2    18.3   0.1    5.2    0.2    0.4    0.0    2.1    0.1    2.3    0.1   6.8    0.3   4.2    0.1   8.7    0.2   2.1    0.0   8.4    0.1
  **menthone**                             1164   5.6      0.2    2.9    0.0    3.5    0.3    \-     \-     6.4    0.1    2.5    0.1    1.4    0.0   5.6    0.2   1.5    0.0   4.2    0.2   2.5    0.0   3.4    0.1
  **iso-menthone**                         1173   0.9      0.0    0.7    0.1    2.3    0.2    \-     \-     1.8    0.1    1.0    0.1    0.5    0.0   3.0    0.1   0.8    0.0   1.3    0.1   1.0    0.0   1.4    0.0
  **iso-menthol**                          1186   11.4     0.4    1.5    0.1    1.9    0.2    \-     \-     4.9    0.2    3.8    0.1    1.1    0.1   6.0    0.3   1.6    0.2   5.8    0.3   3.8    0.1   3.1    0.1
  **neral**                                1247   4.1      0.8    10.0   0.5    14.8   0.7    20.6   0.2    4.1    0.1    2.9    0.0    26.5   0.4   4.8    0.1   14.0   0.3   5.7    0.1   2.9    0.1   11.0   0.2
  **geraniol**                             1255   \-       \-     \-     \-     \-     \-     0.1    0.0    4.1    0.1    0.4    0.0    \-     \-    \-     \-    \-     \-    tr.    ---   0.4    0.0   \-     \-
  **geranial**                             1276   8.6      0.5    14.5   0.6    18.2   0.9    32.1   0.4    6.0    0.0    3.6    0.2    38.5   0.6   6.0    0.6   23.0   0.3   7.6    0.2   3.6    0.1   16.6   0.4
  **isobornyl acetate**                    1296   \-       \-     \-     \-     \-     \-     \-     \-     5.7    0.2    2.6    0.0    0.4    0.0   \-     \-    \-     \-    2.0    0.1   2.6    0.2   tr.    ---
  **menthyl acetat**                       1303   \-       \-     \-     \-     \-     \-     \-     \-     1.4    0.0    34.2   1.0    1.0    0.0   6.5    0.2   7.7    0.4   12.6   0.4   37.4   1.1   2.7    0.3
  **carvacrol**                            1310   \-       \-     \-     \-     \-     \-     \-     \-     0.3    0.0    2.00   0.0    0.2    0.0   1.8    0.0   3.7    0.3   1.8    0.3   2.0    0.0   1.1    0.1
  **eugenol**                              1364   \-       \-     \-     \-     \-     \-     \-            3.9    0.2    tr.    \-     tr.    \-    tr.    \-    tr.    \-    tr.    \-    tr.    \-    tr.    \-
  **E-caryophyllene**                      1427   7.8      0.9    9.1    0.2    7.9    0.1    1.7    0.0    7.8    0.3    3.8    0.1    4.0    0.2   5.1    0.2   9.2    0.5   4.1    0.3   3.8    0.1   8.2    0.3
  **caryophyllene oxide**                  1594   36.0     0.1    20.2   0.2    21.4   0.2    21.6   0.8    19.9   0.3    6.0    0.1    5.8    0.2   14.1   0.5   7.0    0.1   5.6    0.6   6.0    0.1   9.2    0.6
  **humulene epoxide II**                  1620   2.6      0.3    1.3    0.0    1.0    0.0    1.7    0.1    \-     \-     \-     \-     \-     \-    \-     \-    \-     \-    \-     \-    \-     \-    \-     \-
  **14-hydroxy-9-epi-(E)-caryophyllene**   1685   2.7      0.4    4.5    0.1    1.1    0.0    0.4    0.0    \-     \-     \-     \-     \-     \-    \-     \-    \-     \-    \-     \-    \-     \-    \-     \-

^\#^Designation according to [Table 1](#pone.0130714.t001){ref-type="table"}.

IR- retention indices (from temperature-programming, using definition of Van den Dool and Kratz \[[@pone.0130714.ref010]\].

tr.---less than 0.1%.

Lemon balm has sedative, carminative, diaphoretic and antiviral properties. These substances are utilized to help with cases of insomnia that are related to nervous disorders as well as to the functional disorders of the stomach and intestines \[[@pone.0130714.ref015]\]. A single therapeutic dose is 1.5--4.5 g of raw material for a cup of infusion, taken several times a day as required \[[@pone.0130714.ref021], [@pone.0130714.ref022]\], 2--3 g: taken two to three times a day \[[@pone.0130714.ref023]\]. Lemon balm is used in the EU countries both as a food and a medicinal product. The use of the raw material in amounts commonly occurring in food is safe. In the USA, lemon balm has gained the status of GRAS (Generally Recognized as Safe, FDA). The raw material was commonly used in Poland as a food component before 1997.

Chamomile {#sec020}
---------

The yield of essential oil in unprocessed raw material---inflorescence of chamomile was from 0.41% to 0.74% (mean of 0.51%)--[Table 2](#pone.0130714.t002){ref-type="table"}. The concentration of the oil in the chamomile teas being investigated here varied within the range from 0.33 to 0.59% (mean of 0.48%) ([Table 2](#pone.0130714.t002){ref-type="table"}). The pharmacopoeial raw material consists of the dried anthodia of chamomile *Matricaria recutita* L, standardised according to the PP VIII \[[@pone.0130714.ref004]\] for essential oil yield at the level of 0.4%. Chamomile anthodia contain up to 1.5% of oil \[[@pone.0130714.ref024]\]. Six out of the eight analysed chamomile teas met the requirements of PP VIII \[[@pone.0130714.ref004]\].

Taking into account the minimum recommended daily intake of supplements containing chamomile the statistically highest availability of essential oil was found in the powder--7.20 mg (sMC9), and in the capsules--6.24 mg (sMC10). The significantly lowest potential amount of the essential oil for minimum daily intakes were found in the capsules--0.67 mg and 0.71 mg (sMC3, sMC2), and in the tablets--0.72 mg (sMC6). Taking into account the maximum daily intake, the highest potential availability was evidenced by the powder--21.60 mg (sMC9).

An earlier study concerned with the processing of chamomile raw material into granulate revealed significant losses of essential oil when compared to the initial raw material, reaching the level of ca. 44% \[[@pone.0130714.ref012]\]. It was found that the average potential availability of essential oils in products of the type of dietary supplements, for the recommended doses, is circa three times lower than in the equivalent herbal teas. The smaller differences in essential oil ~~content~~ yield in chamomile tea relative to the initial raw material may be related to the kind of secretory structures that in case of chamomile take the form of internal structures, as opposed to the secretory structures of peppermint and lemon balm which have the character of external secretory trichomes and are thus more sensitive to various destructive effects inherent to food processing.

According to the scientific literature available on the topic, the dominant components of chamomile oils are α-bisabolol (1--60%), α-bisabolol oxide A (2%-60%), α-bisabolol oxide B (3--50%), chamazulene (2--25%), α-bisabolone oxide A (0.4--12%) and E-β-farnesene (5--40%), those values are duly confirmed by the results of the study presented here \[[@pone.0130714.ref012], [@pone.0130714.ref013], [@pone.0130714.ref025], [@pone.0130714.ref026]\]. Góra and Lis \[[@pone.0130714.ref013]\] classify several chemotypes of chamomile.

The dominant components in essential oil isolated from unprocessed inflorescence of chamomile are α-bisabolol oxide A (21.7--41.8%), α-bisabolol oxide B (16.7--30.0%), α-bisabolon oxide A (9.9--19.6%), chamazulene (9.6%-18.3%)--[Table 6](#pone.0130714.t006){ref-type="table"}. In the chamomile teas 95 compounds included in the composition of essential oils were identified. In terms of the qualitative composition of essential oil the particular teas did not differ much from each other. The main components of the oils identified are α-bisabolol oxide A (17.4--47.2%), α-bisabolol oxide B (17.8--37.5%), α-bisabolone oxide A (0.3--16.9%), chamazulene (2.7%-13.9%), E-β-farnesene (1.0%-11.4%) ([Table 6](#pone.0130714.t006){ref-type="table"}).

10.1371/journal.pone.0130714.t006

###### The main components of essential oils obtained from unprocessed materials and chamomile teas.

![](pone.0130714.t006){#pone.0130714.t006g}

                                    cMC1[^\#^](#t006fn001){ref-type="table-fn"}   cMC2   cMC3   cMC4   tMC1   tMC2   tMC3   tMC4   tMC5   tMC6   tMC7   tMC8                                                                           
  -------------------------- ------ --------------------------------------------- ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ------ ----- ------ ----- ------ ----- ------ ----- ------ ----- ------ -----
  **E-beta-farnesene**       1457   3.0                                           0.1    1.5    0.1    0.1    0.0    2.3    0.1    1.0    0.1    4.7    0.2    8.3    0.4   8.4    0.8   7.8    0.5   11.4   0.7   9.1    0.6   3.7    0.2
  **spathulenol**            1589   5.4                                           0.2    4.6    0.0    2.9    0.1    3.2    0.1    1.2    0.1    2.9    0.0    2.0    0.0   5.2    0.3   7.0    0.3   0.3    0.0   2.1    0.0   2.9    0.0
  **α-bisabolol oxide B**    1667   30.0                                          0.2    18.4   0.1    26.9   0.2    16.7   0.2    33.6   0.2    34.9   0.1    17.8   0.7   26.6   0.8   31.4   1.2   29.1   0.5   21.8   0.1   37.5   0.8
  **α-bisabolone oxide A**   1695   19.6                                          0.2    10.6   0.1    10.2   0.1    9.9    0.1    16.9   0.4    15.8   0.3    11.8   0.5   12.7   0.9   15.4   0.1   13.5   0.5   11.1   0.6   0.3    0.0
  **chamazulene**            1748   9.6                                           0.2    13.9   0.4    18.3   0.6    17.4   0.1    13.9   0.2    3.5    0.1    2.7    0.1   3.1    0.2   8.8    0.1   4.1    0.1   7.5    0.2   13.1   0.3
  **α-bisabolol oxide A**    1765   21.7                                          0.3    41.0   0.1    30.8   0.8    41.8   0.3    27.0   0.2    28.7   0.4    47.2   1.1   31.9   0.3   17.4   0.3   22.5   0.5   24.5   0.5   27.5   0.5

^\#^Designation according to [Table 1](#pone.0130714.t001){ref-type="table"}.

IR- retention indices (from temperature-programming, using definition of Van den Dool and Kratz \[[@pone.0130714.ref010]\]

tr.---less than 0.1%.

In chemotype A the dominant compound is α-bisabolol oxide A (Egyptian, Slovak, Hungarian and other European chamomiles) \[[@pone.0130714.ref013]\], and three of the chamomile teas tested (tMC3, tMC4, tMC7) are classified as such. Chemotype B is characterised by a dominance of α- bisabolol oxide B (Argentine chamomile oil) \[[@pone.0130714.ref013]\], the remaining five teas analysed being classified in that chemotype. Therefore, it can be assumed that the raw materials used for their production had been imported.

Chamomile and its extracts display diastolic and carminative effects. Water extracts have an immuno-stimulating effect. It is used to treat digestive disorders, inflammatory conditions of the gastrointestinal duct and of the enterospasms. Infusions from chamomile anthodia normalise the work of the intestines and facilitate their peristalsis \[[@pone.0130714.ref015]\]. In gastrointestinal disorders it is recommended to use, 3--4 times a day, a cup of infusion prepared from 3 g of chamomile flowers drowned in hot water \[[@pone.0130714.ref027], [@pone.0130714.ref028]\]. Chamomile inflorescence is used in the EU countries both as a food and a medicinal product. The raw material was commonly used in Poland as a food component before 1997.

When considering the overall results that have been obtained it should be emphasised that peppermint, lemon balm and chamomile teas are a more attractive source of essential oils for our organism than dietary supplements. This fact stems from the lower content of the herbal raw material present in dietary supplements, whose content is many times lower than the therapeutic dose. Moreover, the herbal component of a dietary supplement is subjected to a variety of technological operations (production of tablets, capsules, liquids, powders) which cause a reduction in the overall concentration of essential oil. Significant differences in the levels of the potentially available essential oils in recommended daily dietary supplement intakes are due to the fact that there are no guidelines regulating the content of health- promoting raw material in dietary supplements, with the tendency of having a lower level than the one present in the corresponding medications, which enables the manufacturers to use a big amount margin as far as the relevant ingredients are concerned. The research does not show clear trends regarding the highest amount of potentially available essential oil in a given dietary supplement. Among analysed forms such as tablets, capsules, powders and liquids, when taking into account the potential availability of essential oils, the ones showing the highest values are the powders, which results from the bigger amount of plant raw material being included in a recommended daily intake. However, powders are not appealing to customers, which is visible in the analysed range of supplements, where only 3 out of 30 products were sold in the powder form, whereas the rest was in the form of tablets--11, capsules--10 and lotions --6.

The various forms of dietary supplements such as tablets, capsules, extracts, are all very convenient for the consumer and at the same time they resemble medical potions, which may increase their perceived effectiveness in contrast to food products in the form of traditionally brewed tea bags \[[@pone.0130714.ref029]\]. In spite of the detailed information provided on the label or the attached description concerning the content of the herbal component, the consumers may still have problems with the correct interpretation of the potential availability of a biologically active component when confronted by other products such as herbal teas \[[@pone.0130714.ref030]--[@pone.0130714.ref032]\]. Dietary supplements, in spite of their significantly higher prices compared to such food products as herbal teas, enjoy a high demand among the consumers and the market for such products is constantly growing \[[@pone.0130714.ref033]\]. However, it is important to raise the awareness of the consumers so that they can make conscious and informed choices taking into account not only the attributes related to the simple usage of the products, but also considering the notably more important factor which undoubtedly is the potential availability of active substances present in a given product.

Conclusions {#sec021}
===========

1.  Analysis of the composition of the dietary supplements showed that they contain on average significantly lower amounts of plant material compared to the herbal teas.

2.  It has been shown that the tested herbal teas are characterized by a different yield of the essential oils with an average that is lower than is present in the raw feedstock.

3.  It was found that the average potential availability of essential oils in the products such as dietary supplements for the doses recommended by the producer is lower than in the corresponding tea infusions.

4.  The essential oils extracted from herbal teas have similar chemical profiles with the individual components of the quantitative variation characteristics for the raw materials.
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